Integra LifeSciences Holdings Corporation
IART
$22.34
-$1.62-6.74%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 16.23% | -8.93% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 16.23% | -8.93% | |||
| Cost of Revenue | 8.61% | -2.75% | |||
| Gross Profit | 21.92% | -13.06% | |||
| SG&A Expenses | 4.84% | -6.14% | |||
| Depreciation & Amortization | -1.20% | 1.43% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 6.36% | -4.12% | |||
| Operating Income | 155.98% | -46.74% | |||
| Income Before Tax | 210.70% | -34.09% | |||
| Income Tax Expenses | 132.13% | -247.36% | |||
| Earnings from Continuing Operations | 281.72% | 13.76% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 281.72% | 13.76% | |||
| EBIT | 155.98% | -46.74% | |||
| EBITDA | 132.49% | -48.50% | |||
| EPS Basic | 281.77% | 12.67% | |||
| Normalized Basic EPS | 259.55% | -61.23% | |||
| EPS Diluted | 280.57% | 12.61% | |||
| Normalized Diluted EPS | 259.55% | -61.23% | |||
| Average Basic Shares Outstanding | -0.04% | -1.24% | |||
| Average Diluted Shares Outstanding | -0.04% | -1.24% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
